United Therapeutics Medical retweeted
📣 REMINDER: 3️⃣ #ISHLTResearchGrants are accepting applications—further your research career by applying.
The research grants cover topics related to:
❤️ #CardiogenicShock
🫁 Development of acellular Ex Vivo Lung Perfusion (#EVLP) technologies
🧬 #Biomarkers and #AI in #LungTX
United Therapeutics Medical retweeted
📣Exciting news! We’re thrilled to announce a new chapter in the leadership of PVRI’s Innovative Drug Discovery Initiative (IDDI). We warmly welcome industry reps, Gil Golden (UTC) and @SidraHoffman (Gossamer Bio), to the IDDI Leadership Team. They’ll be joining @SandeepSahayMD and Luke Howard @HelpMyBreathing, who remain on as IDDI Leaders.
Our heartfelt thanks to Peter Fernandes and Sylvia Nikkho, who are stepping down from their roles. Their dedication has laid a strong foundation for the future of the IDDI, and we are very grateful that Sylvia will remain active in several Workstreams.
See their profiles: pvrinstitute.org/iddi-workst…
Together, we’re building the future of pulmonary vascular drug discovery. 💊💡
#PulmonaryHypertension #DrugDiscovery #ClinicalResearch #PHCommunity
United Therapeutics Medical retweeted
Join @LungBioengineering on 17 June for a one-hour webinar where leading experts from Europe and the US will discuss two pivotal ex vivo lung perfusion (#EVLP) consensus documents and different approaches on selecting allografts for EVLP, the implications for resource utilization, and clinical outcomes. 🫁📅
Free to register: bit.ly/4jnHMo1
United Therapeutics Medical retweeted
Watch a webinar recording to enhance your understanding and management of pulmonary hypertension in patients with ILD. Leading clinical experts discuss the latest approaches in early detection and diagnosis, as well as therapeutic advancements, for PH-ILD. hubs.la/Q039ZXTS0
United Therapeutics Medical retweeted
What are the biggest challenges you face in managing patients with #PulmonaryHypertension?
0%Time constraints
0%Keeping up with research
0%Patient adherence
100%Access to key resources
1 votes • Final results United Therapeutics Medical retweeted
As #PulmonaryArterialHypertension (PAH) progresses, the arteries stiffen, and pulmonary arterial compliance (PAC) is reduced. Decreased PAC has been shown to be a significant predictor of mortality in PAH. Learn more: hubs.ly/Q035dpnR0
@UTHRMed
#PulmonaryHypertension
United Therapeutics Medical retweeted
In alignment with the Organ Procurement and Transplant Network Expeditious Task Force’s Bold Aim, applications are now open for US #LungTransplant programs to join the Lung Transplant Growth Collaborative, facilitated by the Institute for Healthcare Improvement. 1/2
United Therapeutics Medical retweeted
The 2025 United Therapeutics Jenesis awards™ applications are now open! These awards support investigators in the US or Canada who are engaged in #PulmonaryHypertension, idiopathic #PulmonaryFibrosis, and #LungTransplant research. Find more details at unither.com/medical-professi…
United Therapeutics Medical retweeted
Join us for a webinar on understanding management of pulmonary hypertension in patients with ILD. Leading clinical experts will discuss the latest approaches in early detection and diagnosis, as well as therapeutic advancements, for PH- ILD. Register now: hubs.la/Q032xYNy0
United Therapeutics Medical retweeted
What type of #PulmonaryHypertension resources would be most useful to have in your clinic?
80%Educational brochures
0%Diagnostic guidelines
0%Patient self-management
20%Telehealth resources
5 votes • Final results United Therapeutics Medical retweeted
Honored to be a recipient of the Jenesis Innovative Research Awards, supporting our research in risk stratifying dnDSA lung transplant patients using cell-free DNA. Grateful for this opportunity to advance the field!
The Jenesis Innovative Research Awards™ provide support to US-based investigators engaged in innovative research advancing scientific knowledge and enhancing patient care in #PulmonaryHypertension, idiopathic #PulmonaryFibrosis, or #LungTransplant. 1/4
United Therapeutics Medical retweeted
It is a great honor to receive the Jenesis award on Social Determinants of Health. Our work aims to understand mechanisms of social inequality and metrics of allostatic load in patients with Pulmonary Hypertension @UTHRMed @IUPCCM @RFPMachado @mardigomberg
United Therapeutics Medical retweeted
Join us at @accpchest #CHEST2024 for a presentation on inhaled prostacyclin therapy in patients with #PulmonaryHypertension. This session will be led by Anthony Hickey, Jennifer H Keeley, and Jean M Elwing (@ElwingJean). Register here: tyvasodpi2024.com/
United Therapeutics Medical retweeted
“We all know we need more lung donors.” - @CDemarest_MDPhD, introducing her talk on her experience using EVLP with Lung Bioengineering at @VUMCTransplant.
United Therapeutics Medical retweeted
SPONSORED: Join us at the #MechSummit2024 for a lunch symposium on September 21st! Discover insights on DCD lung evaluation using EVLP with Drs. Jack Haney, Kunal Patel, and Gregory Bittle! 🫁✨
#LungBioengineering #LungTransplant #EVLP
United Therapeutics Medical retweeted
Join us at @PHAssociation #PHA2024 for a presentation on the management of inhaled prostacyclin therapy in patients with #PulmonaryHypertension. This session will be led by Lori Reed, MSN, APRN, FPN-C, and Jennifer H Keeley, DNP, ANP-BC. Register here: tyvasodpi2024.com
United Therapeutics Medical retweeted
We are pleased to introduce you our Social Media Ambassadors!
They will share their own experience in real time during the Symposium. Follow them and #WSPH2024
@jeanlucvachiery
@TamCardio
@Montanidavid
@RyanTedfordMD
United Therapeutics Medical retweeted
Join us at @atscommunity #ATS2024 for a presentation discussing studies involving treprostinil induction strategies in #PulmonaryHypertension. This session will be led by Dr. Chad Miller. Register here: expedite2024.com
United Therapeutics Medical retweeted
It is almost time for @atscommunity #ATS2024. Our medical affairs colleagues will be at booth 2607— see you there! We will also have several scientific presentations. While a few are highlighted below, you can find more information here: ir.unither.com/press-release…. 1/7
United Therapeutics Medical retweeted
Join us at @ACCinTouch #ACC24 for a presentation discussing a study involving a treprostinil induction strategy in #PulmonaryHypertension. This session will be led by Dr. Ronald J. Oudiz. Register here: expedite2024.com






























